CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fresenius SE & Co KGaA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fresenius SE & Co KGaA
Else-Kroener Strasse 1
Phone: +49 61726080p:+49 61726080 BAD HOMBURG, 61352  Germany Ticker: FREFRE
Business Summary
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
8092 Kidney dialysis centers
8748 Business consulting services, not elsewhere classified
3845 Electromedical and electrotherapeutic apparatus
8062 General medical and surgical hospitals
8069 Specialty hospitals, except psychiatric
8099 Health and allied services, not elsewhere classified
3841 Surgical and medical instruments and apparatus
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
1542 General contractors-nonresidential buildings, other than industrial
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Supervisory Board WolfgangKirsch 69 5/21/2021 5/21/2021
Chairman of the Management Board MichaelSen 56 10/1/2022 4/12/2021
Honorary Chairman of the Supervisory Board GerdKrick 86 5/21/2021 5/28/2003
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
FRESENIUS FINANCE (JERSEY) LTD
FRESENIUS FINANCE I, S.A.
Fresenius Finance II B.V. Netherlands
19 additional Subsidiary records available in full report.

Business Names
Business Name
0B52
0OO9
APP Pharmaceuticals, Inc.
27 additional Business Names available in full report.

General Information
Number of Employees: 193,865 (As of 12/31/2023)
Outstanding Shares: 563,237,277 (As of 12/31/2023)
Shareholders: 789
Stock Exchange: ETR


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 16, 2024